Notably, ASNS is frequently upregulated in tumors and is associated with poor prognosis of several types of cancer, such as prostate cancer, glioma and neuroblastoma (Sircar et al., 2012; Zhang et al., 2014). Here, ASNS is linked to prostate carcinoma.